mimiX Biotherapeutics
Edit

mimiX Biotherapeutics

http://www.mimixbio.com/
Last activity: 16.10.2023
Categories: 3DAudioEngineeringFastIndustryMaterialsProductResearchSkinTechnology
MimiX biotherapeutics introduces Sound Induced Morphogenesis. We extend the boundaries of biofabrication, making bioengineered, artificial human organs and tissues a future reality. Sound Induced Morphogenesis (SIM) is a revolutionary approach in biofabrication. It mirrors nature’s design, to aggregate and pattern biologicals by tuning sound profiles under contactless, fast and delicate culture conditions resulting in a morphologically induced tissue generation. We introduce cymatiX®, a unique acoustic biofabrication solution that makes the Sound Induced Morphogenesis technology easily accessible to the scientific and clinical community Visit www.mimixbio.com to learn more. mimiX biotherapeutics is a Swiss biomedical company.
Followers
91
Followers
2.64K
Website visits
5.4K /mo.
Mentions
9
Location: Switzerland, Neuchatel
Employees: 11-50
Founded date: 2019

Investors 2

Mentions in press and media 9

DateTitleDescription
16.10.2023Fresh capital brings Mimix a step closer to commercialization
18.09.2023Moving forward with experienced Board members
19.07.2023Swiss Medtechs seek growth opportunities in Boston
16.03.2023Swiss startups prepare to visit the US East Coast
23.02.2023Support from seasoned global industry leaders
21.12.2022Mimix Biotherapeutics’ innovative skin graft a step closer to the market
02.06.2022Concordia researchers develop ‘game-changing’ ultrasound 3D printing technologyResearchers from Concordia University have developed a novel direct sound printing (DSP) technique that leverages ultrasound waves to fabricate complex and precise objects. The team has published a paper describing the technology, which wor...
28.10.20213D Systems to expand bioprinting program after buying Volumetric Biotechnologies for $400MU.S. 3D printer manufacturer 3D Systems has unveiled plans to expand on its bioprinting program after acquiring Volumetric Biotechnologies for $400 million. Bought for an initial $45 million, with a further $355 million set to be paid upon ...
22.10.2019Experienced serial-entrepreneur joins Microcity Startup Program

Reviews 0

Sign up to leave a review

Sign up Log In